Table 5.
Local Anesthetic | Bupivacaine | Lidocaine | ||
---|---|---|---|---|
Concentration Range | Low (~0.01 mM) |
High (max. 15 mM) |
Low (~0.02 mM) |
High (max. 17 mM) |
Clinical Location | Intravascular | Extravascular | Intravascular | Extravascular |
Effect on PMNs | ||||
Viability | ↔ | ↔ | ↔ | ↔ |
CD66b (“Activation”) | ↔ | ↔ | ↔ | ↔ |
CD62L or CD11b (“Adhesion”) | ↔ | ↔ | ↔ | ↔ |
Chemotactic migration | ↔ | ↓↓↓ | ↑ | ↓↓↓ |
Induction period of ROS-production | ↔ | ↓↓↓ | ↔ | ↓↓↓ |
Intensity of ROS-production | ↔ | ↔ | ↔ | ↔ |
Duration until NETosis-Onset | ↓ | ↓↓↓ | ↑ | ↓↓↓ |
Note: ↔ indicates no change, ↑/↓ indicates slight increase or decrease and ↓↓↓ indicates strong decrease.